— Know what they know.
Not Investment Advice

DXB.AX ASX

Dimerix Limited
1W: +0.0% 1M: -22.4% 3M: -11.8% YTD: -57.5% 1Y: -50.0%
A$0.23 ($0.16)
-0.01 (-4.26%)
 
Weekly Expected Move ±6.0%
A$0 A$0 A$0 A$0 A$0
ASX · Healthcare · Biotechnology · Tech Score Strong Sell · Power 33 · A$135.1M mcap · 471M float · 0.412% daily turnover

Income Trends

Revenue
$4M +246.7% ▲
5Y CAGR: -0.4%
Gross Profit
$4M +235.7% ▲
5Y CAGR: -0.8%
Operating Income
-$37M -2.3% ▼
Net Income
-$30M -125.0% ▼
EPS (Diluted)
$-0.05 -110.6% ▼
EBITDA
-$37M -2.3% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2022FY2023FY2024FY2025FY2026
Revenue$6M$37K$583K$1M$4M
YoY Growth+45.6%-99.4%+1486.1%+115.0%+246.7%
Cost of Revenue$51K$56K$0$0$138K
Gross Profit$6M$37K$583K$1M$4M
Gross Margin99.2%100.0%100.0%100.0%96.8%
R&D Expenses$14M$20M$21M$27M$36M
SG&A Expenses$3M$2M$5M$5M$5M
Operating Expenses$17M$23M$26M$38M$41M
Operating Income-$10M-$23M-$25M-$36M-$37M
Operating Margin-162.4%-62040.9%-4325.1%-2896.7%-854.6%
Interest Expense$1K$0$0$0$0
Income Before Tax-$10M-$14M-$17M-$32M-$37M
Tax Expense-$6M-$9M-$8M-$18M-$7M
Net Income-$10M-$14M-$17M-$13M-$30M
Net Margin-162.3%-37521.4%-2926.4%-1056.3%-685.3%
EPS (Diluted)$-0.04$-0.04$-0.04$-0.02$-0.05
EBITDA-$16M-$23M-$25M-$36M-$37M
Shares Outstanding300M326M453M560M600M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms